SCHEMBL6993956

SCHEMBL6993956

O=C(COc1cccc(-c2n[nH]c3c2Cc2ccccc2-3)c1)NCCN1CCOCC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.56
CHEK1 O14757 11/20 0.51
KDR P35968 2/20 0.50
MAPK1 P28482 1/20 0.48
HBB P68871 1/20 0.48
RET P07949 2/20 0.48
MARK3 P27448 2/20 0.48
RPS6KA3 P51812 2/20 0.48
MELK Q14680 2/20 0.48
MARK2 Q7KZI7 2/20 0.48
BRSK1 Q8TDC3 2/20 0.48
AURKB Q96GD4 2/20 0.48
MAP4K4 O95819 1/20 0.48
PHKG2 P15735 1/20 0.48
RPS6KB1 P23443 1/20 0.48
FLT3 P36888 1/20 0.48
PRKAA1 Q13131 1/20 0.48
MINK1 Q8N4C8 1/20 0.48
ABL1 P00519 1/20 0.47
PRMT5 O14744 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6997182 0.93 CHEK1 (0.51) HSD17B10CHEK1KDRRETMARK3
SCHEMBL7699601 0.85 CHEK1 (0.62) CHEK1KDRRETMARK3RPS6KA3
SCHEMBL7703429 0.85 CHEK1 (0.63) CHEK1KDRRETMARK3RPS6KA3
SCHEMBL7090440 0.81 KDR (0.46) CHEK1KDRFLT3CDK2
SCHEMBL7094673 0.81 CD274 (0.59) CHEK1KDRMAPK1
SCHEMBL7096426 0.80 CHEK1 (0.54) CHEK1KDRMAPK1
Water SCHEMBL7695501 0.80 CD274 (0.58) CHEK1KDRMAPK1
SCHEMBL7701720 0.79 CHEK1 (0.54) CHEK1KDRMAPK1LMNA
SCHEMBL7000821 0.79 KDR (0.62) CHEK1KDRCDK2
SCHEMBL7088696 0.78 KDR (0.57) CHEK1KDRCDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP claimed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO claimed
EP-1289525-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS Abbott GmbH & Co. KG (DE) 2003-03-12 EP disclosed
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed
WO-2001087846-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS ABBOTT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG & COMPANY KOMMANDITGESELLSCHAFT (DE) 2001-11-22 WO disclosed
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP disclosed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO disclosed